e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
Molecular biology: state-of-the-art 2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2013 abstract - Abnormal neutrophil migration is a feature of early COPD, present across disease phenotypes and causally related to increased phosphoinositide-3-kinase signalling
G. Walton, J. Stockley, A. Usher, R. Stockley, E. Sapey (Birmingham, United Kingdom)
Source:
Annual Congress 2013 –Molecular biology: state-of-the-art 2013
Session:
Molecular biology: state-of-the-art 2013
Session type:
Oral Presentation
Number:
4872
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Walton, J. Stockley, A. Usher, R. Stockley, E. Sapey (Birmingham, United Kingdom). LSC 2013 abstract - Abnormal neutrophil migration is a feature of early COPD, present across disease phenotypes and causally related to increased phosphoinositide-3-kinase signalling. Eur Respir J 2013; 42: Suppl. 57, 4872
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
LSC 2013 abstract - Activin-A is up-regulated in severe asthma and is associated with angiogenesis
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
LSC 2013 abstract - Mechanisms regulating enhanced alphavbeta6 expression in pulmonary fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
LSC - 2021 - SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021
LSC 2010 Abstract: TNFα promoter polymorphism is associated with increased local production and enhanced downstream inflammation in COPD
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
LSC 2013 abstract - NF-κbeta acts downstream of EGFR in regulating low dose cadmium induced primary lung cell proliferation
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
Effect of rHuKGF in vegf dependent cell survival progression in emphysematous condition via akt signalling pathway
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Low apoptosis rate as a reason of local immune cell accumulation in interstitial lung diseases (ILD). The role of cytokine network
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006
PI3K and notch signal pathways coordinately regulate the activation and proliferation of T lymphocytes in asthma
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Growth related oncogene α (Groα) does not relate to inflammatory change in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 482s
Year: 2005
rHuKGF optimistically attenuates MAPK/ERK mediated cell proliferation pathway in emphysematous lungs
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
A role for WNT-5B in airway remodeling in COPD by activation of TGF-beta/Smad3 signaling?
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Consensus network analysis reveals pathways associated with lung function decline in both COPD and IPF
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
Targeting the mTOR signaling pathway to inhibit lung cell senescence in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
LSC 2010 Abstract: Genetic defects in TGF-β signaling results in relatively mild abnormalities in lung development, which together with side stream cigarette smoke exposure predisposes to and accelerates onset of emphysema
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Year: 2020
LSC 2013 abstract - Unravelling VEGF165 signalling in the lung
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept